Skip to content
healthcare.dev
Get a free key

ITVISMA

NDC 71894-200, onasemnogene abeparvovec-brve, injection, suspension, from Novartis Innovative Technologies Inc..

Product NDC
71894-200
Status
Listed
Labeler
Novartis Innovative Technologies Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRATHECAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125856
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71894-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONASEMNOGENE ABEPARVOVEC40000000000000 [arb'U]/mL
Package NDCNDC-11Package
71894-200-02718940200021 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ab2e1c6c-4f95-4243-9296-1734e0a30591

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71894-200

Use it

Look up 71894-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71894-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71894-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.